These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2141947)

  • 1. Specifics of Experimental Modeling 8-OH-DPAT-Induced Perseverative Behavior in Mice.
    Kudryashov NV; Volkova AV; Shimshirt AA; Naplekova PL; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2023 May; 175(1):41-44. PubMed ID: 37338756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-HT
    Humby T; Smith GE; Small R; Davies W; Carter J; Bentley CA; Winstanley CA; Rogers RD; Wilkinson LS
    Psychopharmacology (Berl); 2020 Jun; 237(6):1745-1756. PubMed ID: 32123974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.
    Pratt WE; Clissold KA; Lin P; Cain AE; Ciesinski AF; Hopkins TR; Ilesanmi AO; Kelly EA; Pierce-Messick Z; Powell DS; Rosner IA
    Brain Res; 2016 Oct; 1648(Pt A):54-68. PubMed ID: 27431937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.
    Greenshaw AJ; Silverstone PH
    Drugs; 1997 Jan; 53(1):20-39. PubMed ID: 9010647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake.
    Tomkins DM; Higgins GA; Sellers EM
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):173-9. PubMed ID: 7862892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action.
    Fernández-Guasti A; Hong E; López-Rubalcava C
    Psychopharmacology (Berl); 1992; 107(1):61-8. PubMed ID: 1350351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition.
    Shepherd JK; Rodgers RJ
    Psychopharmacology (Berl); 1990; 101(3):408-13. PubMed ID: 2141947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
    Dourish CT; Hutson PH; Curzon G
    Brain Res Bull; 1985 Oct; 15(4):377-84. PubMed ID: 2933126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat.
    Dourish CT; Hutson PH; Curzon G
    Psychopharmacology (Berl); 1985; 86(1-2):197-204. PubMed ID: 3161115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural specificity of 8-OH-DPAT-induced feeding.
    Montgomery AM; Willner P; Muscat R
    Psychopharmacology (Berl); 1988; 94(1):110-4. PubMed ID: 2964671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-OH-DPAT elicits feeding and not chewing: evidence from liquid diet studies and a diet choice test.
    Dourish CT; Clark ML; Iversen SD
    Psychopharmacology (Berl); 1988; 95(2):185-8. PubMed ID: 2970649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Hacksell U; Nilsson JL; Hjorth S; Carlsson A; Lindberg P; Sanchez D; Wikstrom H
    J Med Chem; 1981 Aug; 24(8):921-3. PubMed ID: 6460101
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.